We are live on ! Find out more
KURA icon

Kura Oncology
KURA

104 hedge funds and large institutions have $531M invested in Kura Oncology in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,978% more call options, than puts

Call options by funds: $547K | Put options by funds: $9K

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

17% more capital invested

Capital invested by funds: $455M → $531M (+$76.3M)

14% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 28

5% more funds holding

Funds holding: 99 → 104 (+5)

1.26% less ownership

Funds ownership: 85.21% → 83.95% (-1.3%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
104
Holders Change
+5
Holders Change %
+5.05%
% of All Funds
2.25%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
16
Increased
32
Reduced
28
Closed
11
Calls
$547K
Puts
$9K
Net Calls
+$538K
Net Calls Change
+$673K

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$13.1M
2
Goldman Sachs
Goldman Sachs
New York
+$9.57M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.59M
4
FI
Fosun International
China
+$1.57M
5
Man Group
Man Group
United Kingdom
+$1.5M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$16.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.77M
3
BI
BVF Inc
California
-$4.31M
4
AVM
Arch Venture Management
Illinois
-$3.85M
5
PM
Prosight Management
Texas
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$1.87M +$492K +31,923 +39%
CIA
27
Capital Impact Advisors
Massachusetts
$1.84M – – –
AGA
28
Altrinsic Global Advisors
Connecticut
$1.74M – – –
Man Group
29
Man Group
United Kingdom
$1.61M +$1.5M +97,057 New
Allianz Asset Management
30
Allianz Asset Management
Germany
$1.52M +$5.56K +361 +0.4%
AA
31
ALPS Advisors
Colorado
$1.52M +$61.2K +3,974 +5%
MA
32
Minerva Advisors
Pennsylvania
$1.47M – – –
CCP
33
Clough Capital Partners
Massachusetts
$1.33M – – –
Two Sigma Investments
34
Two Sigma Investments
New York
$1.13M +$1.05M +68,175 New
SIM
35
Spark Investment Management
New York
$1.07M +$997K +64,700 New
TCIM
36
TIAA CREF Investment Management
New York
$922K +$136K +8,813 +19%
TA
37
Teachers Advisors
New York
$846K – – –
Adage Capital Partners
38
Adage Capital Partners
Massachusetts
$830K +$770K +50,000 New
Swiss National Bank
39
Swiss National Bank
Switzerland
$748K +$44.7K +2,900 +7%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$724K -$54.3K -3,524 -7%
Wells Fargo
41
Wells Fargo
California
$682K +$101K +6,581 +19%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$665K +$171K +11,100 +38%
Citigroup
43
Citigroup
New York
$664K -$1.11M -71,979 -64%
B
44
Bailard
California
$639K +$131K +8,500 +28%
DCM
45
DAFNA Capital Management
California
$606K -$1.73M -112,059 -75%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$602K -$12.5K -809 -2%
Rafferty Asset Management
47
Rafferty Asset Management
New York
$506K +$470K +30,528 New
BG
48
Bellevue Group
Switzerland
$486K +$451K +29,300 New
PPCM
49
Pillar Pacific Capital Management
California
$466K -$15.4K -1,000 -3%
AllianceBernstein
50
AllianceBernstein
Tennessee
$426K -$13.9K -900 -3%
1
2
3 4 5

KURA Hedge Fund Activity: Q1 2019 in Review

104 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2019, worth a combined $531M — up 17% from $455M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KURA positions and 11 closed out — a net gain of 5 holders — while 32 added to existing stakes and 28 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $13.1M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $16.1M sold.

  • 104 institutional investors held Kura Oncology (KURA) as of Q1 2019, up from 99 in Q4 2018.
  • Funds reported $531M of Kura Oncology stock for Q1 2019, up 17% quarter-over-quarter.
  • 16 funds opened new Kura Oncology positions in Q1 2019 and 11 closed out, a net change of +5 holders.
  • The largest Kura Oncology buyer in Q1 2019 was Cormorant Asset Management, an estimated $13.1M added.
  • The largest Kura Oncology seller in Q1 2019 was PFM Health Sciences, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2019.